Bristol-Myers Squibb
BMY
#178
Rank
NZ$205.02 B
Marketcap
NZ$100.42
Share price
-1.43%
Change (1 day)
17.68%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): NZ$5.96

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$5.93. an increase over its 2024 EPS that were of NZ-$7.57.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025NZ$5.91-178.05%
2024NZ-$7.57-213.92%
2023NZ$6.6530.2%
2022NZ$5.10-6.04%
2021NZ$5.43-179.29%
2020NZ-$6.85-281%
2019NZ$3.79-27.06%
2018NZ$5.19
2016NZ$4.57175.26%
2015NZ$1.66-19.83%
2014NZ$2.07-22.44%
2013NZ$2.6734.48%
2012NZ$1.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.08 221.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.33 108.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.33-60.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$4.10-30.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$39.44 565.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.55 314.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.54-40.31%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$15.13 155.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.52 111.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$10.16 71.39%๐Ÿ‡ฌ๐Ÿ‡ง UK